Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Magnetic Resonance Imaging|May 3, 2011
Automated registration of sequential breath-hold dynamic contrast-enhanced MR images: a comparison of three techniquesSivaramakrishnan Rajaraman, Jeffrey J Rodriguez, Christian Graff, et al.
NMR in Biomedicine|November 20, 2008
Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathwayDavid L Morse, Danielle Carroll, Sam Day, et al.
Journal of Clinical Medicine|July 2, 2020
Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade GliomaDaniel J Glazar, G Daniel Grass, John A Arrington, et al.
Research Square|October 4, 2023
Rules-based Volumetric Segmentation of Multiparametric MRI for Response Assessment in Recurrent High-Grade GliomaHarshan Ravi, Samuel H Hawkins, Olya Stringfield, et al.
Radiology. Imaging Cancer|February 3, 2023
Pretherapy Ferumoxytol-enhanced MRI to Predict Response to Liposomal Irinotecan in Metastatic Breast CancerHarshan Ravi, Andres M Arias-Lorza, James R Costello, et al.
Physics and Imaging in Radiation Oncology|July 23, 2024
Prediction of radiologic outcome-optimized dose plans and post-treatment magnetic resonance images: A proof-of-concept study in breast cancer brain metastases treated with stereotactic radiosurgeryShraddha Pandey, Tugce Kutuk, Mahmoud A Abdalah, et al.
Clinical Imaging|September 13, 2025
Quantitative habitat concentration analysis of triple negative breast cancer on MRI correlates with pathologic response to combination neoadjuvant immuno/chemotherapyR Jared Weinfurtner, Dana Ataya, Kimberly Funaro, et al.
Journal of Breast Imaging|March 3, 2026
Ductal Carcinoma In Situ Active Monitoring Trials: Do Eligibility Criteria Identify Patients at Low Risk for Upgrade to Invasive Carcinoma?Dana K Ataya, K Ruwani M Fernando, Jasmine Brainerd, et al.
Cancer Research|March 12, 2009
Bicarbonate increases tumor pH and inhibits spontaneous metastasesIan F Robey, Brenda K Baggett, Nathaniel D Kirkpatrick, et al.
Scientific Reports|September 4, 2020
Dose-response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulinAndres M Arias Lorza, Harshan Ravi, Rohit C Philip, et al.
Pageof 6